2 September 2026 Biologics Clinical research Hidradenitis Suppurativa Evaluating the cost and efficacy of HS biologics
2 September 2026 Dermatology Dermatomyositis Rheumatology FDA approves first oral dermatomyositis drug
2 September 2026 Clinical research Dermatology Paediatrics Pharmaceuticals JAK inhibitors beneficial in paediatric AA
2 September 2026 Biologics psoriatic arthritis Research Oral TYK2 inhibitor holds PsA gains to one year
19 August 2026 Alopecia Areata Clinical research Dermatology Further evidence for JAK inhibitors in severe AA
5 August 2026 Atopic Dermatitis Clinical research Dermatitis/Eczema Respiratory Early respiratory infections linked to childhood eczema risk
